PRESS RELEASE published on 10/23/2024 at 09:01, 2 years ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen Scherzer & Co. AG veröffentlicht Halbjahreszahlen 2024. Analyse von GSC Research GmbH bewertet Aktie als Kauf mit Kursziel 3,00 Euro. Unbefriedigende Ergebnisse, aber Potenzial durch Portfolioreserven Kaufempfehlung Scherzer & Co. AG GSC Research GmbH Halbjahreszahlen 2024 Portfolioreserven
PRESS RELEASE published on 05/16/2024 at 11:31, 2 years 5 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen GSC Research GmbH stuft Scherzer & Co. AG positiv ein mit einem Kursziel von 3,00 Euro in 12 Monaten. Analyse hebt ermutigende Entwicklungen im Portfolio hervor, insbesondere potenzielle Gewinne aus Abfindungswerten Scherzer & Co. AG GSC Research GmbH Kursziel 3,00 Euro Abfindungswerte Anlagestrategie
PRESS RELEASE published on 02/14/2024 at 16:26, 2 years 8 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen Analyse der GSC Research GmbH zur Scherzer & Co. AG bekräftigt 'Kaufen'-Empfehlung mit Kursziel 3,00 Euro. Unternehmen verzeichnet Verluste, aber langfristig positive Performance erwartet Kaufempfehlung Scherzer & Co. AG GSC Research GmbH Small- Und Mid-Cap-Szene NAV-Berechnung
PRESS RELEASE published on 02/14/2024 at 16:06, 2 years 8 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen Analyse von GSC Research GmbH zu Scherzer & Co. AG basierend auf den vorl ufigen Gesch ftszahlen 2023. Empfehlung zum Kauf mit Kursziel von 3,00 Euro. Analyse zeigt Potenzial f r berdurchschnittliche Performance Kaufempfehlung Scherzer & Co. AG GSC Research GmbH Geschäftszahlen 2023 Kurspotenzial
PRESS RELEASE published on 09/26/2023 at 13:26, 3 years 1 month ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen
PRESS RELEASE published on 05/24/2023 at 10:37, 3 years 5 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen
PRESS RELEASE published on 02/09/2023 at 12:31, 3 years 8 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen
PRESS RELEASE published on 01/13/2023 at 12:12, 3 years 9 months ago Original-Research: Scherzer & Co. AG (von GSC Research GmbH): Kaufen
Published on 11/02/2026 at 17:00, 18 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 18 minutes ago QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/02/2026 at 16:15, 1 hour 3 minutes ago ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/02/2026 at 15:00, 2 hours 18 minutes ago CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Published on 11/02/2026 at 14:00, 3 hours 18 minutes ago GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 16:00, 1 hour 18 minutes ago Shares Admitted to Trading and Total Voting Rights
Published on 11/02/2026 at 15:58, 1 hour 20 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 11/02/2026 at 15:19, 1 hour 59 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/02/2026 at 15:19, 1 hour 59 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/02/2026 at 15:25, 1 hour 53 minutes ago Guillemot Corporation S.A. | Informations relatives au nombre total de droits de vote et d’actions 31/10/2026
Published on 11/02/2026 at 15:25, 1 hour 53 minutes ago Guillemot Corporation S.A. | Information regarding the total number of voting rights and shares 31/10/2026
Published on 11/02/2026 at 08:40, 8 hours 37 minutes ago Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/30/2026 at 23:00, 2 days 18 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
